Post Discharge After Surgery Virtual Care with Remote Automated Monitoring Technology-2 (PVC-RAM-2) Trial
Condition(s) studied
Investigational drug(s) / intervention(s)
Virtual care with remote automated monitoring: Use of Cloud Diagnostics connected health kit for at home monitoring with virtual clinical from nursing and perioperative physician team.
Study summary
The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology-2 (PVC-RAM-2) Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on acute-hospital care during the 45-day follow up after randomization, in adults who have undergone semi-urgent (e.g., oncology), urgent (e.g., hip fracture), or emergency (e.g., ruptured abdominal aortic aneurysm) surgery. Secondary outcomes at 45 days after randomization include 1) days in hospital; 2) index length of hospital stay; 3) hospital re-admission; 4) emergency department visit; 5) medication error detection; 6) medication error correction; and 7) surgical site infection. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 45 days. We will also assess optimal management of long-term health by evaluating among self-reported current smokers and those with atherosclerotic disease, whether patients are taking classes of efficacious medications at 45 days post randomization.
Eligibility
Primary outcome measure(s)
- Acute-hospital care — 45 days post randomization
Composite outcome of hospital re-admission and emergency department visit, which includes urgent-care centre visit.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Hamilton General Hospital | Hamilton | Ontario | Recruiting |
| Juravinski Hospital | Hamilton | Ontario | Recruiting |
More Population Health Research Institute trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04876950 on ClinicalTrials.gov ↗ ← All trials in Canada